Abstract
Background: To date, no pediatric studies have highlighted the impact of center's ventricular assist device (VAD) volumes on post implant outcomes. Methods: Children (age <19) enrolled in Pedimacs undergoing initial left ventricular assist device implantation from 2012 to 2020 were included. Center volume was analyzed as a continuous and categorical variable. For categorical analysis, center volumes were divided as: low volume (1-15 implants), medium volume (15-30 implants), and high volume (>30 implants) during our study period. Patient characteristics and outcomes were compared by center's VAD volumes. Results: Of 44 centers, 16 (36.4%) were low, 11 (25%) were medium, and 17 (38.6%) were high-volume centers. Children at high-volume centers were least likely intubated, sedated, or paralyzed, and most likely ambulating preimplant (p < 0.05 for all). Center's VAD volumes were not a significant risk factor for mortality post implant when treated as a continuous or a categorical variable (p > 0.05). Compared to low volume, children at high-volume centers had fewer early neurological events. Compared to medium volume, those at high-volume centers had fewer late bleeding events (p < 0.05 for all). There were no significant differences in survival after an adverse event by hospital volumes (p > 0.05). Conclusions: Although hospital volume does not affect post-VAD implant mortality, pediatric centers with higher VAD volumes have fewer patients intubated, sedated, paralyzed pre implant, and have lower adverse events. Failure to rescue was not significantly different between low, medium, and high-volume VAD centers.
Original language | English (US) |
---|---|
Pages (from-to) | 787-796 |
Number of pages | 10 |
Journal | Journal of Heart and Lung Transplantation |
Volume | 43 |
Issue number | 5 |
DOIs | |
State | Published - May 2024 |
Funding
The data for this research were provided by The Society of Thoracic Surgeons’ National Database Participant User File Research Program. Data analysis was performed at the investigators’ institution(s). The views or opinions presented in this document are solely those of the author(s), and do not represent those of The Society of Thoracic Surgeons. S.A. is site PI for a multicenter study led by the University of Michigan—reports no salary support. A.L. is a consultant for Abbott, Syncardia, Medtronic, Abiomed, Bayer, and Berlin Heart Inc. D.M. is a consultant for Abbot, Berlin Heart, CorMatrix/Azyio, Medtronic, and Syncardia Systems. D.S. is a consultant for Abbott. B.M. reports grant support from the Single Ventricle Research Fund Grant, payments for expert tesitmony; serving on the DSMB for a study (no conflict). All other authors have nothing to disclose.
Keywords
- center volume
- failure to rescue
- pediatric
- postimplant outcomes
- ventricular assist device
ASJC Scopus subject areas
- Surgery
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine
- Transplantation